Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party

Bazarbachi, A; Boumendil, A; Finel, H; Mohty, M; Castagna, L; Peggs, KS; Blaise, D; ... Sureda, A; + view all Bazarbachi, A; Boumendil, A; Finel, H; Mohty, M; Castagna, L; Peggs, KS; Blaise, D; Afanasyev, B; Diez-Martin, JL; Sierra, J; Bloor, A; Martinez, C; Robinson, S; Malladi, R; El-Cheikh, J; Corradini, P; Montoto, S; Dreger, P; Sureda, A; - view fewer (2018) Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. British Journal of Haematology , 181 (1) pp. 86-96. 10.1111/bjh.15152 .

https://ift.tt/2JjRnPv